Press Release 04.04.24
Ann M. Kim is an associate who focuses her practice on general corporate matters, including capital markets, venture capital financings, mergers and acquisitions, and securities law compliance.
Representative Experience
- Represented Nikola Corporation, an integrated truck and energy company transforming commercial transportation with its Class 8 vehicles, in its $275 million common stock and green convertible senior notes offerings.
- Represented Acer Therapeutics Inc., a leading pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, in its $2.675 million registered direct offering and concurrent private placement.
- Represented Bilt Rewards, the leading loyalty platform specializing in rent and neighborhood rewards, in its $200 million financing, which increased its valuation to $3.1 billion.
View More
- Represented Invitae Corporation, a leading medical genetics company, in its ATM equity offering.
- Represented Vasa Therapeutics Inc., a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging, in its $6 million Series Seed financing.
- Represented a chip design company in its Series C financing.
- Represented a technology platform company in its $6 million Series C-2 financing.
Professional Highlights
- Before law school, Ann worked at a startup in Sweden and a large law firm in Los Angeles. During law school, she interned at a private fintech company and received the American Jurisprudence Award (First in Class) in Negotiations. Ann graduated with a Business Law certificate and Pro Bono Honors.
Education
-
J.D., University of California, Berkeley School of Law (Berkeley Law), 2022
Articles Editor, Berkeley Business Law JournalB.A., University of California, Berkeley, 2017
Magna cum laude; Phi Beta Kappa
Admissions
-
California
Languages
-
Korean